Aminopyridazines inhibit β-amyloid-induced glial activation and neuronal damage in vivo

Medicine and Dentistry

• Neuroinflammation 100%
• Hippocampus 100%
• Amyloid Protein 100%
• Inflammatory Cytokine 100%
• Chronic Inflammation 50%
• Alzheimer's Disease 50%
• Cytokine 50%
• Biological Marker 50%
• Tumor Necrosis Factor 50%
• Disease Exacerbation 50%
• Amyloid Beta 50%
• Interleukin 1 50%
• Amyloid Plaque 50%
• Glia 50%
• Neurodegenerative Disorder 50%
• Intracerebroventricular Drug Administration 50%
• S100B 50%
• Microglia 50%
• Astrocyte 50%
• Comorbidity 50%

Neuroscience

• In Vivo 100%
• Amyloid Protein 100%
• Hippocampus 66%
• Cytokine 66%
• Neurodegenerative Disorder 33%
• Beta Amyloid 33%
• Glia 33%
• Proinflammatory Cytokine 33%
• Interleukin 1 33%
• Alzheimer's Disease 33%
• Astrocyte 33%
• Microglia 33%
• Necrosis 33%
• Comorbidity 33%
• Plaque 33%

Pharmacology, Toxicology and Pharmaceutical Science

• Cytokine 100%
• Amyloid Protein 100%
• Nervous System Inflammation 66%
• Biological Marker 33%
• Disease Exacerbation 33%
• Tumor Necrosis Factor 33%
• Interleukin 1 33%
• Chronic Inflammation 33%
• Amyloid Plaque 33%
• Alzheimer's Disease 33%
• Comorbidity 33%